Skip to content

Intrinsic Periodic Pattern of Breathing

Study of Periodic Breathing in Healthy Humans

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02201875
Acronym
PERHYP1
Enrollment
120
Registered
2014-07-28
Start date
2014-09-30
Completion date
2015-12-31
Last updated
2014-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercapnia, Hyperoxia, Hypoxia, Normoxia

Keywords

hypoxia, exercise, periodic breathing, hypercapnia, apneas, cardiac failure

Brief summary

We made a fortuitous observation of periodic breathing in a healthy subject coming to our outpatient mountain medicine consultation at Avicenne hospital in Bobigny (France). During this consultation, subjects perform a hypoxia exercise test, which allows a good prediction of their risk factors for severe high altitude illnesses. Surprisingly, breath-by-breath recording of the ventilation signal showed a periodic breathing pattern, which increased when the subject started to exercise in hypoxic conditions and was maintained during normoxic exercise. Therefore, our objective was to confirm this observation in a retrospective study led in 82 subjects who passed this test. We tested the hypothesis that subjects with a brisk ventilatory response to hypoxia might show a more pronounced periodic pattern of ventilation, due to a higher gain of the chemoreceptor feedback loop. Then, our objective is to investigate the mechanisms involved in the periodic pattern in healthy subjects, as a function of exercise intensity, altitude intensity, role of peripheral and central chemoreceptors to O2 and CO2. Finally, we want to investigate the possible role of this ventilatory instability in patients with obstructive or central apneas.

Detailed description

In a preliminary study, among the population coming to the outpatient consultation of mountain medicine at Avicenne hospital in 2012, 82 subjects (38 females and 44 males) were randomly selected and separated in two groups of 41 high and 41 low responders to hypoxia according to the median value of the hypoxic ventilatory response to hypoxia at exercise (HVRe \> or \< 0.84 L/min/kg) derived from the hypoxic exercise test (inspired fraction of O2: 0.115, exercise intensity of 30% of maximal aerobic power), as previously described. The hypoxic exercise test consists in 4 successive phases of 3 to 4 minutes each with the following sequence: rest in normoxia (RN), rest in hypoxia (RH), exercise in hypoxia (EH) and exercise in normoxia (EN). Minute ventilation ( E, L.min-1) is measured through a metabograph (Vmax Encore, SensorMedics, Yorba Linda, CA). Pulse O2 saturation (SpO2, %) is measured by transcutaneous oximetry (Nellcor N-595, Nellcor, Pleasanton, CA) on a pre-warmed ear lobe. End tidal PCO2 (PETCO2) is measured by infrared thermopile (Vmax Encore, SensorMedics, Yorba Linda, CA). During the whole test, VE, SpO2 and PETCO2 were recorded breath-by-breath. Continuous blood pressure is measured by a Finapres system. Data are transferred to a computer for further spectrum analysis. A Fast Fourier Transform (FFT) is then applied to the ventilation signal in sequences of 128 points in each phase of the test. This method will allow us to detect the presence of peaks in the frequency domain of the ventilation signal. Two main parameters are derived from the FFT: the frequency in hertz (or period in seconds) of the larger peak and its power estimated as the area under the peak at ± 0.02 Hz around the peak (in L2.s-2). The main study will be designed in order to unravel the mechanisms and role of these oscillations in ventilation. An overall population of 90 healthy subjects and 30 patients will be included in the study. Step 1. Effect of exercise intensity. Step 2. Effect of altitude level. Step 3. Effect of the stimulation of central chemoreceptors by acetazolamide. Step 4. Effect of inhibiting the peripheral chemoreceptors by hyperoxia. Step 5. Effect of inhibiting the peripheral chemoreceptors by hyperoxia and stimulating the central chemoreceptors by hypercapnia. Step 6. Evaluating the presence of these oscillations in patients with sleep apneas. Step 7. Evaluating the presence of these oscillations in patients with cardiac failure.

Interventions

None listed

Sponsors

Association pour la Recherche en Physiologie de l'Environnement
Lead SponsorOTHER

Study design

Observational model
COHORT

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* depending on the group: see definition of groups

Exclusion criteria

* BMI \> 30 * history of severe cardiac arrhythmia * pulmonary hypertension * history of coronary disease

Design outcomes

Primary

MeasureTime frameDescription
Periodic pattern of ventilationThe measure is made at the end of the 6-min exercise period, only once in each condition (normoxia, hypoxia, hyperoxia, hypercapnia),Presence of oscillation in the ventilation signal

Secondary

MeasureTime frameDescription
Oscillations in heart rateThe measure is made at the end of the 6-min exercise period, only once in each condition (normoxia, hypoxia, hyperoxia, hypercapnia)Presence of oscillations in the beat-by-beat ECG signal with a specific peak in the frequency spectrum
Oscillations in arterial blood pressureThe measure is made at the end of the 6-min exercise period, only once in each condition (normoxia, hypoxia, hyperoxia, hypercapnia)Presence of oscillations in the systolic/diastolic value of instant arterial blood pressure, measured non-invasively.

Countries

France

Contacts

Primary ContactJean-Paul Richalet, MD, PhD
richalet@univ-paris13.fr33148387758

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026